Navigation Links
TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights
Date:3/26/2008

31, December 31,

2007 2006

(Unaudited)

Assets

Current assets

Cash and cash equivalents $ 32,500 $ 55,383

Prepaid expenses and other current assets 835 581

Total current assets 33,335 55,964

Long-term assets 5,317 7,471

Total assets $ 38,652 $ 63,435

Liabilities and stockholders' equity

Current liabilities $ 9,036 $ 12,270

Debt and other long-term liabilities 973 4,413

Deferred revenue 2,183 2,183

Total liabilities 12,192 18,866

Total stockholders' equity 26,460 44,569

Total liabilities and stockholders' equity $ 38,652 $ 63,435

TorreyPines Therapeutics, Inc.

Condensed Consolidated Statements of Operations

(in thousands, except share and per share amounts)

Three months ended Twelve months ended

December 31, December 31,

2007 2006 2007 2006

(Unaudited) (Unaudited) (Unaudited)

Revenue $ 2,461 $ 2,461 $ 9,850 $ 9,850

Operating expenses:

Research and development 7,587 4,713 27,977 22,353

General and administrative 1,434 1,985 5,643 3,971

Purchased in-process

research and development - 8,328 - 8,328


'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia
2. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
3. TorreyPines Therapeutics Reports Third Quarter 2007 Results
4. TorreyPines Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
6. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
7. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
8. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
9. Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board
10. Blake M. Paterson MD, CEO and Co-founder of Alba Therapeutics, Wins Greater Baltimore Committee 2008 Leadership in Bioscience Award
11. Cell Therapeutics, Inc. (CTI) Invest Northwest Presentation to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... BioPlus Specialty Pharmacy ... has an expanded team of Regional Pharmaceutical Care ... prescriber offices in their regions, with specific areas ... a variety of Regional Pharmaceutical Care Liaisons specializing ... hepatitis C help prescribers understand all the new ...
(Date:12/19/2014)... 2014 Reports from CDC ... suffer from one or more chronic health conditions - ... can address some of these diseases, but may not ... sufferers face. While implanted nerve stimulation devices today offer ... nerve, which can induce side effects. , To ...
(Date:12/19/2014)... 2014 With only 2 weeks left ... on Sartorius Biohit products . The product specials include ... Electronic Pipette Trade-in Program, and free pipette tips. , ... around the world. They are ideal for lab technicians ... ,     Full volume range of 0.1 uL ...
(Date:12/19/2014)... , Dec. 18, 2014 Relmada Therapeutics, ... for the treatment of chronic pain, announced the results ... "This was a transformational year in Relmada,s ... future for our company," said Sergio Traversa , ... we have executed on key financial, human resource and ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2
... CryoLife, Inc. (NYSE: CRY ),a biomaterials, medical ... A. Theodore has been named vice president, general,counsel, ... directly to,Steven G. Anderson, chairman, president and chief ... Mr. Theodore will be responsible for all corporate,legal ...
... Dr. Andreas Krause to Present on Statistical Considerations for Model, ... and Simulation ... ... (OTC Bulletin Board: PHST), a leading provider of software and,strategic ...
... The 100 Most-Promising Private Technology Ventures Celebrated at Event in ... ... Sept. 3 /Xinhua-PRNewswire/ -- Red Herring,Magazine announced that the leading China ... winner of the,prestigious ,Red Herring 100 Asia, 2007 awards. The news ...
Cached Biology Technology:CryoLife Names Philip Theodore as Vice President, General Counsel 2Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 2Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 3Miaxis Biometrics Named as 'Red Herring 100 Asia' Award Winner for 2007 2Miaxis Biometrics Named as 'Red Herring 100 Asia' Award Winner for 2007 3
(Date:12/4/2014)... PALM BEACH GARDENS, Fla. , Dec. 3, ... identity management solutions, today announced that its DigitalPersona ... 4500 fingerprint readers have been deployed throughout ... Carolina , South Carolina ... network headquartered in Southern Pines, North ...
(Date:11/21/2014)... YORK , Nov. 19, 2014  Earlier this ... at New York College, and one of the most ... biosensor signals that are transmitted from Smartphones to third ... were Smartphones and has one of the earliest known ... discussing its usage in the military, child care, elder ...
(Date:11/18/2014)... Nov. 18, 2014  The Secure Identity & ... today jointly announce the formation of The Airport ... its Identity and Biometric Entry and Exit ... received official support from BORDERPOL, the international non-profit ... and provide expertise regarding border security, traveler and ...
Breaking Biology News(10 mins):First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
... conflict in Sri Lanka kills more than 70 humans and ... tools in combating these conflicts is moving the elephants into ... done in hopes of avoiding problems that include elephants raiding ... But according to a new study to be published Dec. ...
... release is available in German . ... new Research Units and one new Clinical Research Unit. This ... meeting in Bonn. The purpose of the collaborations is to ... in their subject areas and to establish innovative work directions. ...
... Long ago, when life on Earth was in its infancy, ... vast prehistoric ocean by beating whip like tails called flagella. ... 800 million years later, these organisms have evolved into parasites ... ocean may be the key to stopping them. The ...
Cached Biology News:Relocating elephants fails to decrease human-wildlife conflict 23 new research units, 1 new clinical research unit 23 new research units, 1 new clinical research unit 3UGA researchers find algal ancestor is key to how deadly pathogens proliferate 2
... Recognizes K+ Cl- Cotransporter-1 ... no significant sequence homology ... CCC.,SPECIES REACTIVITIES: The immunogen ... in human, mouse, porcine ...
...
Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
oligophrenin-1 (H-100)...
Biology Products: